Suppr超能文献

二苯乙烯和三联苯化合物对寄生虫的抗寄生虫作用。

Antiparasitic Effect of Stilbene and Terphenyl Compounds against Parasites.

作者信息

Bruno Federica, Castelli Germano, Vitale Fabrizio, Catanzaro Simone, Badaco Valeria Vitale, Roberti Marinella, Colomba Claudia, Cascio Antonio, Tolomeo Manlio

机构信息

National Reference Center for Leishmaniasis (C.Re.Na.L.), Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi 3, 90129 Palermo, Italy.

Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.

出版信息

Pharmaceuticals (Basel). 2021 Nov 22;14(11):1199. doi: 10.3390/ph14111199.

Abstract

BACKGROUND

Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite . No progress in the treatment of this pathology has been made since Nifurtimox was introduced more than fifty years ago, and this drug is considered very aggressive and may cause several adverse effects. This drug currently has severe limitations, including a high frequency of undesirable side effects and limited efficacy and availability, so research to discover new drugs for the treatment of Chagas disease is imperative. Many drugs available on the market are natural products as found in nature or compounds designed based on the structure and activity of these natural products.

METHODS

This study evaluated the in vitro antiparasitic activity of a series of previously synthesized stilbene and terphenyl compounds in epimastigotes and intracellular amastigotes. The action of the most selective compounds was investigated by flow cytometric analysis to evaluate the mechanism of cell death. The ability to induce apoptosis or caspase-1 inflammasomes was assayed in macrophages infected with after treatment, comparing it with that of Nifurtimox.

RESULTS

The stilbene ST18 was the most potent compound of the series. It was slightly less active than Nifurtimox in epimastigotes but most active in intracellular amastigotes. Compared to Nifurtimox, it was markedly less cytotoxic when tested in vitro on normal cells. ST18 was able to induce a marked increase in parasites positive for Annexin V and monodansylcadaverine. Moreover, ST18 induced the activation, in infected macrophages, of caspase-1, a conserved enzyme that plays a major role in controlling parasitemia, host survival and the onset of the adaptive immune response in Trypanosoma infection.

CONCLUSIONS

The antiparasitic activity of ST18 together with its ability to activate caspase-1 in infected macrophages and its low toxicity toward normal cells makes this compound interesting for further clinical investigation.

摘要

背景

恰加斯病,又称美洲锥虫病,是由原生动物寄生虫引起的一种潜在威胁生命的疾病。自五十多年前硝呋莫司被引入以来,这种疾病的治疗一直没有进展,而且这种药物被认为具有很强的刺激性,可能会引起多种不良反应。这种药物目前存在严重局限性,包括不良反应发生率高、疗效有限以及可及性差,因此研发治疗恰加斯病的新药势在必行。市场上的许多药物都是天然产物或基于这些天然产物的结构和活性设计的化合物。

方法

本研究评估了一系列先前合成的芪类和三联苯化合物对体外培养的前鞭毛体和细胞内无鞭毛体的抗寄生虫活性。通过流式细胞术分析研究了最具选择性的化合物的作用,以评估细胞死亡机制。在处理后感染的巨噬细胞中检测诱导凋亡或半胱天冬酶 -1炎性小体的能力,并与硝呋莫司进行比较。

结果

芪类化合物ST18是该系列中最有效的化合物。它在前鞭毛体中的活性略低于硝呋莫司,但在细胞内无鞭毛体中活性最高。与硝呋莫司相比,在体外对正常细胞进行测试时,它的细胞毒性明显更低。ST18能够使膜联蛋白V和单丹磺酰尸胺呈阳性的寄生虫显著增加。此外,ST18在感染的巨噬细胞中诱导了半胱天冬酶 -1的激活,这是一种保守酶,在控制锥虫感染中的寄生虫血症、宿主存活和适应性免疫反应的发生中起主要作用。

结论

ST18的抗寄生虫活性及其在感染的巨噬细胞中激活半胱天冬酶 -1的能力以及对正常细胞的低毒性,使得该化合物有望进行进一步的临床研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf2/8617688/4fefacca4783/pharmaceuticals-14-01199-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验